Eiko Lifesciences share news, announcements and annual reports
BSE: 540204Chemicals & PetrochemicalsSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹51.52.
30 Oct: open ₹52.64, high ₹52.93, low ₹50.27
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹74 Cr3,149th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.08
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,609
Eiko Lifesciences share news and announcements
531 announcements, routine notices left out, newest first. Page 7 of 11.
Jan 2022
5 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2021
22 Nov · Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (LODR) Regulation, 2015 - 30.09.2021
2 Nov · Outcome For The Board Meeting_02.11.2021
Oct 2021
20 Oct · Board meeting
Meeting on 2 Nov 2021: quarterly results7 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....6 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2021
30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....27 Sep · Intimation For Change In Website Of The Company
Aug 2021
26 Aug · Meeting
26 Aug · Reg. 34 (1) Annual Report
Jul 2021
23 Jul · Board meeting
Meeting on 30 Jul 2021: quarterly results3 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 03 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....
Jun 2021
25 Jun · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
2 Jun · Shareholding for the Period Ended May 12, 2021
Shareholding Pattern for the Period Ended May 12, 2021. For more details, kindly Click ....
May 2021
12 May · Board meeting
Meeting on 12 May 2021: preferential issue of shares
Apr 2021
28 Apr · Related Party Transactions Of The Company For The Year Ended March 31, 2021
20 Apr · Declaration Pursuant To Regulation 33(3)(D) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
12 Apr · Board meeting
Meeting on 20 Apr 2021: audited results5 Apr · Certificate From Practicing Company Secretary
3 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....3 Apr · COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 FOR THE HALF YEAR AND YEAR ENDED 31.03.2021
3 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 02 Apr · Results
Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Mar 2021
31 Mar · Outcome Of Eogm